Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 20Terminated 6Recruiting 6Unknown 5Withdrawn 3Active not recruiting 3

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Genitourinary 3Dermatologic 2Gastrointestinal 1

Conditions

Prostatic Neoplasms 240Carcinoma, Renal Cell 75Urinary Bladder Neoplasms 56Kidney Neoplasms 32Breast Neoplasms 26Neoplasms 25Carcinoma, Transitional Cell 22Neoplasm Metastasis 21Carcinoma, Non-Small-Cell Lung 14Sarcoma 11Non-Muscle Invasive Bladder Neoplasms 11Lung Neoplasms 11Melanoma 10Wilms Tumor 8Testicular Neoplasms 8Colorectal Neoplasms 8Uterine Cervical Neoplasms 7Urologic Neoplasms 7Stomach Neoplasms 7Pancreatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Recurrence 6Ovarian Neoplasms 6Endometrial Neoplasms 6Carcinoma, Hepatocellular 6Carcinoma 6Prostatic Neoplasms, Castration-Resistant 5Neuroblastoma 5Esophageal Neoplasms 5

Interventions

bintrafusp alfa protein, human 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms, Germ Cell and Embryonal × Genitourinary × Clear all
NCT06940804 2025-07-02

AVENTURINE

BioNTech SE

Phase 2 Withdrawn
Genitourinary

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT04791228 2025-01-01

A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors

Children's National Research Institute

Phase 2 Withdrawn
GastrointestinalGenitourinarySarcoma

Carcinoma, Carcinoma, Hepatocellular, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

NCT04648826 2021-12-17

Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
DermatologicGenitourinarySarcoma

Carcinoma, Renal Cell, Melanoma, Neoplasms, Germ Cell and Embryonal, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡